NCT00956228View on ClinicalTrials.gov

Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Prostatic Neoplasm
Interventions
RADIATION

radioimmuniguided intenstiy modulated radiotherapy

All patients recieved 75.6 Gy in 42 fractions to the prostate and the region of the prostate which enhanced on prostascint scan was simaltaneously boosted to a total dose of 82 Gy

Trial Locations (1)

Unknown

Mayo Clinic, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT00956228 - Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate Cancer | Biotech Hunter | Biotech Hunter